Anna Krygowska‐Wajs

2.5k total citations
42 papers, 733 citations indexed

About

Anna Krygowska‐Wajs is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Anna Krygowska‐Wajs has authored 42 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Neurology, 13 papers in Cellular and Molecular Neuroscience and 8 papers in Molecular Biology. Recurrent topics in Anna Krygowska‐Wajs's work include Parkinson's Disease Mechanisms and Treatments (31 papers), Neurological disorders and treatments (12 papers) and Neurological diseases and metabolism (6 papers). Anna Krygowska‐Wajs is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (31 papers), Neurological disorders and treatments (12 papers) and Neurological diseases and metabolism (6 papers). Anna Krygowska‐Wajs collaborates with scholars based in Poland, United States and Ireland. Anna Krygowska‐Wajs's co-authors include Urszula Fiszer, Krzysztof Owczarek, Zbigniew K. Wszołek, Matthew J. Farrer, Ryan J. Uitti, Timothy Lynch, Owen A. Ross, Grzegorz Opala, Andrzej Szczudlik and Maria Barcikowska and has published in prestigious journals such as PLoS ONE, Neurology and The Lancet Neurology.

In The Last Decade

Anna Krygowska‐Wajs

40 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Krygowska‐Wajs Poland 16 501 184 131 105 98 42 733
Daan C. Velseboer Netherlands 7 638 1.3× 144 0.8× 72 0.5× 88 0.8× 88 0.9× 10 798
Shishuang Cui China 14 390 0.8× 97 0.5× 175 1.3× 67 0.6× 97 1.0× 33 658
Valentina Nicoletti Italy 14 429 0.9× 157 0.9× 95 0.7× 58 0.6× 87 0.9× 21 717
H. Mejía United States 8 682 1.4× 251 1.4× 72 0.5× 123 1.2× 175 1.8× 9 847
Nikola Kresojević Serbia 16 396 0.8× 161 0.9× 90 0.7× 103 1.0× 149 1.5× 43 703
Silvia Jesús Spain 17 510 1.0× 194 1.1× 175 1.3× 153 1.5× 143 1.5× 40 766
Takayasu Mishima Japan 14 418 0.8× 132 0.7× 110 0.8× 69 0.7× 51 0.5× 61 601
Gian Pal United States 14 414 0.8× 162 0.9× 65 0.5× 80 0.8× 53 0.5× 53 572
Jorge Hernández‐Vara Spain 17 522 1.0× 153 0.8× 56 0.4× 73 0.7× 94 1.0× 42 679
Sara Pietracupa Italy 18 596 1.2× 168 0.9× 95 0.7× 100 1.0× 82 0.8× 32 805

Countries citing papers authored by Anna Krygowska‐Wajs

Since Specialization
Citations

This map shows the geographic impact of Anna Krygowska‐Wajs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Krygowska‐Wajs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Krygowska‐Wajs more than expected).

Fields of papers citing papers by Anna Krygowska‐Wajs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Krygowska‐Wajs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Krygowska‐Wajs. The network helps show where Anna Krygowska‐Wajs may publish in the future.

Co-authorship network of co-authors of Anna Krygowska‐Wajs

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Krygowska‐Wajs. A scholar is included among the top collaborators of Anna Krygowska‐Wajs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Krygowska‐Wajs. Anna Krygowska‐Wajs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krygowska‐Wajs, Anna, Agata Furgała, Jiaqi Li, et al.. (2024). Associations between gut microbiota characteristics and non‐motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients. Neurogastroenterology & Motility. 36(8). e14846–e14846. 2 indexed citations
2.
Chalimoniuk, Małgorzata, Ewa Jówko, Józef Langfort, et al.. (2020). Gene polymorphisms and motor levodopa‐induced complications in Parkinson's disease. Brain and Behavior. 10(3). e01537–e01537. 18 indexed citations
3.
Kulikowski, Konrad, et al.. (2015). The effect of deep brain stimulation of subthalamic nucleus on cognitive functions in Parkinson's disease – Pilot study. Parkinsonism & Related Disorders. 22. e106–e107. 2 indexed citations
4.
Trenkwalder, Claudia, К. Ray Chaudhuri, Pablo Martínez‐Martín, et al.. (2015). Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial. The Lancet Neurology. 14(12). 1161–1170. 90 indexed citations
5.
Krygowska‐Wajs, Anna & Urszula Fiszer. (2014). Znaczenie aktywności fizycznej w chorobie Parkinsona. Via Medica Journals. 10(2). 66–70.
6.
Hoffman‐Zacharska, Dorota, Dariusz Koziorowski, Owen A. Ross, et al.. (2013). Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease. Parkinsonism & Related Disorders. 19(11). 1057–1060. 65 indexed citations
7.
Furgała, Agata, et al.. (2013). Efficacy of deep brain stimulation of the subthalamic nucleus on autonomic dysfunction in patients with Parkinson's disease.. PubMed. 53(2). 15–22. 10 indexed citations
8.
Puschmann, Andreas, Christophe Verbeeck, Michael G. Heckman, et al.. (2011). Human leukocyte antigen variation and Parkinson’s disease. Parkinsonism & Related Disorders. 17(5). 376–378. 30 indexed citations
9.
Dächsel, Justus C., Christian Wider, Carles Vilariño‐Güell, et al.. (2010). Death-associated protein kinase 1 variation and Parkinson’s disease. European Journal of Neurology. 18(8). 1090–1093. 5 indexed citations
10.
Soto‐Ortolaza, Alexandra I., Bahareh Behrouz, Christian Wider, et al.. (2009). Calbindin‐1 association and Parkinson’s disease. European Journal of Neurology. 17(2). 208–211. 10 indexed citations
11.
Jasińska‐Myga, Barbara, Christian Wider, Grzegorz Opala, et al.. (2009). GRN 3′UTR+78 C>T is not associated with risk for Parkinson’s disease. European Journal of Neurology. 16(8). 909–911. 8 indexed citations
12.
Ross, Owen A., Alexandra I. Soto, Carles Vilariño‐Güell, et al.. (2008). Genetic variation of Omi/HtrA2 and Parkinson's disease. Parkinsonism & Related Disorders. 14(7). 539–543. 53 indexed citations
13.
Ross, Owen A., Michael G. Heckman, Alexandra I. Soto, et al.. (2008). Dopamine β-hydroxylase −1021C>T association and Parkinson's disease. Parkinsonism & Related Disorders. 14(7). 544–547. 10 indexed citations
14.
Stocchi, Fabrizio, et al.. (2007). Clinical Efficacy of a Single Afternoon Dose of Effervescent Levodopa-Carbidopa Preparation (CHF 1512) in Fluctuating Parkinson Disease. Clinical Neuropharmacology. 30(1). 18–24. 30 indexed citations
15.
Krygowska‐Wajs, Anna. (2006). Przedkliniczny i wczesny okres choroby Parkinsona - diagnostyka i możliwości leczenia neuroprotekcyjnego. Via Medica Journals. 2(4). 177–182. 1 indexed citations
16.
Krygowska‐Wajs, Anna, Jennifer M. Kachergus, Mary Hulihan, et al.. (2005). Clinical and genetic evaluation of 8 Polish families with levodopa-responsive parkinsonism. Journal of Neural Transmission. 112(11). 1487–1502. 2 indexed citations
17.
Toft, Mathias, Jan Aasly, Gina Bisceglio, et al.. (2004). Parkinsonism, FXTAS, and FMR1 premutations. Movement Disorders. 20(2). 230–233. 44 indexed citations
18.
Krygowska‐Wajs, Anna, Jennifer Hussey, Mary Hulihan, et al.. (2003). Two large Polish kindreds with levodopa-responsive Parkinsonism not linked to known Parkinsonian genes and loci. Parkinsonism & Related Disorders. 9(4). 193–200. 3 indexed citations
19.
Krygowska‐Wajs, Anna, Andrzej Szczudlik, Lucyna Antkiewicz‐Michaluk, Irena Romańska, & J Vetulani. (1998). [Salsolinol, 3-O-methyl-dopa and homovanillic acid in the cerebrospinal fluid of Parkinson patients].. PubMed. 31(5). 875–85. 6 indexed citations
20.
Kałuza, J, Anna Krygowska‐Wajs, & Piotr Czapiński. (1998). Acute hemorrhagic encephalitis (Hurst disease) associated with neuroaxonal dystrophy.. PubMed. 36(4). 221–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daan C. Velseboer Breakdown of academic impact, for papers by Shishuang Cui Breakdown of academic impact, for papers by Valentina Nicoletti Breakdown of academic impact, for papers by H. Mejía Breakdown of academic impact, for papers by Nikola Kresojević Breakdown of academic impact, for papers by Silvia Jesús Breakdown of academic impact, for papers by Takayasu Mishima Breakdown of academic impact, for papers by Gian Pal Breakdown of academic impact, for papers by Jorge Hernández‐Vara Breakdown of academic impact, for papers by Sara Pietracupa
Rankless by CCL
2026